Boothbay Fund Management’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
Boothbay Fund Management's NXTC Position: Q3 2026 in Review
Boothbay Fund Management sold out of NextCure (NXTC) in Q3 2026, closing a stake of 84,687 shares — an estimated $135K sold.
Boothbay Fund Management first reported a position in NXTC in Q3 2020 and held it in 10 quarters. The position peaked at $988K in Q4 2025. 29 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.
- Boothbay Fund Management reported no remaining NextCure position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 84,687 NextCure shares in Q3 2026, an estimated $135K.
- Boothbay Fund Management first reported a position in NextCure in Q3 2020 and held it in 10 quarters.
- Boothbay Fund Management's NextCure position peaked at $988K in Q4 2025.
- 29 funds tracked by Wall St. Rank held NextCure as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.